Genetically engineered BPI variant proteins

Details Genetically engineered BPI variant proteins Genetically engineered BPI variant proteins

1992-07-22

1998-06-23

Sidberry, Hazel F.

Chemistry: natural resins or derivatives; peptides or proteins;

Proteins, i.e., more than 100 amino acid residues

514 12, 514 21, 435 691, C07K 1400, C07K 14435, A61K 3803, A61K 3817

Patent

active

057706948

ABSTRACT:
The present invention provides a composition comprising a BPI Protein and an anionic compound which composition exhibits (1) no bactericidal activity and (2) endotoxin neutralizing activity. Also, this invention provides methods for using BPI Proteins.

REFERENCES:
patent: 84335 (1868-01-01), Elsbach
patent: 5171739 (1992-12-01), Scott et al.
M.N. Marra, et al. (1990) J. Immunol., 144:662-666.
P. Elsbach, et al. (1988) Bacteria-Host Cell Interaction, pp. 47-60.
P. Gray, et al. (1988) Clinical Research, 36(3):620A.
P. Gray, et al. (1989) The Journal of Biological Chemistry 264(16):9505.
J. Weiss, et al. (1982) The American Society of Clinical Investigation, Inc. 69:959.
J. Weiss, et al. (1985) The American Society of Clinical Investigation, Inc. 76:206.
S. Leong, et al. J. Cell Biochem. Suppl. 13:66 (1989).
J. Weiss, et al., Infection and Immunity, 38:1149-1153 (1982).
K. Muello, et al. Clinical Research, 31:371A.
J. Weiss, et al. J. Clin. Invest., 71:540-549 (1983).
W.M. Shafer, et al. Infection and Immunity, 45:29-35 (1984).
C.J. Hovde, et al. Infection and Immunity, 54:142-148 (1986).
J. Weiss, et al. Infection and Immunity, 51:594-599 (1986).
J.K. Spitznagel, et al. J. Immunol., 139:1291-1296 (1987).
M.M. Shafer, et al. Infection and Immunity, 55:1536-1539 (1987).
G.I. Veld, et al. Infection and Immunity, 56:1203-1208 (1988).
M.M. Farley, et al. Infection and Immunity, 56:1589-1592 (1988).
B.A. Mannion et al., J. Immunol. 142:2807-2812 (1989).
J. Weiss, et al. (1985) ASCI Metabolism, 33(2):567(A).
B.A. Mannion et al., J. Clin. Invest. 85:853-860 (1990).
A.H. Pereira, et al., Blood 76:825-834 (1990).
R.R. Schumann, et al. Science 249:1429-1431 (1990).
Larrick et al., "Complementary DNA Sequence of Rabbit Cap 18--A Unique Lipopolysaccharide Binding Protein," Biochem. Biophys. Research Communications (1991) 179:170-175.
Ooi et al., "Endotoxin-Neutralizing Properties of the 25 kD N-Terminal Fragment and a Newly Isolated 30kD C-Terminal Fragment of the 55-60 kD Bactericidal/Permeability-increasing Protein of Human Neutrophils," J. Exp. Med. (1991) 174:649-655.
Gray et al., "Cloning of the cDNA of a Human Neutrophil Bactericidal Protein," J. Biol. Chem. (1989) 264:9505-9509.
Weiss, J. et al. (1975), "Partial Characterization and Purification of a Rabbit Granulocyte Factor that Increases Permeability of Escherichia coli, " J. Clin. Invest. 55:33-42.
Morrison et al. (1976), "Binding of Polymyxin B to the Lipid A Portion of Bacterial Lipopolysaccharides," Immunochemistry 13:813-818.
Morrison et al. (1978), "The Effects of Bacterial Endotoxins on Host Mediation Systems," Am. J. Pathol. 93(2):527-617.
Weiss et al. (1978), "Purification and Characterization of a Potent Bacteriacidal and Membrane Active Protein from the Granules of Human Polymorphonuclear Leukocytes," J. Biol. Chem. 253:2664-2672.
Elsbach et al. (1979), "Separation and Purification of a Potent Bactericidal/Permeability-increasing Protein and a Closely Associated Phospholipase A.sub.2 from Rabbit Polymorphonuclear Leukocytes," J. Biol. Chem. 254:11000-11009.
Weiss et al. (1982), "Killing of Gram-Negative Bacteria by Polymorphonuclear Leukocytes," Am. Society Clin. Invest. 69:959-970.
Weiss et al. (1982), "Sensitivity of K1-Encapsulated Escherichia coli to Killing by the Bactericidal/Permeability-Increasing Protein of Rabbit and Human Neutrophils," Infect. Immun. 38:1149-1153.
Weiss et al. (1983), "Role of Charge and Hydrophobic Interactions in the Action of the Bactericidal/Permeability-Increasing Protein of Neutrophils on Gram-negative Bacteria," J. Clin. Invest. 71:540-549.
Muello et al. (1983), "The Role Endotoxin in the Action of the Bactericidal/Permeability Increasing Neutrophil Protein on the Bacterial Envelope," Clinical Research 31(2):371A.
Shenep et al. (1984), "Kinetics of Endotoxin Release During Antibiotic Therapy For Experimental Gram-Negative Bacterial Sepsis," J. Infect. Dis. 150(3):380-388.
Shafer et al. (1984), "Cationic Antimicrobial Proteins Isolated from Human Neutrophil Granulocytes in the Presence of Diisopropyl Fluorophosphate," Infection and Immunity 45:29-35.
Weiss et al. (1984), "The Role of Lipopolysaccharides in the Action of the Bactericidal/Permeability-Increasing Neutrophil Protein on the Bacterial Envelope," J. Immunol. 132(6):3109-15.
Duma, R.J., (1985), "Gram-Negative Bacillary Infections," Am. J. of Med. 78(Suppl. 6A):154-164.
Weiss et al. (1985), "Oxygen-Independent Intracellular and Oxygen-Dependent Extracellular Killing of Escherichia coli S15 by Human Polymorphonuclear Leukocytes," The American Society of Clinical Investigation, Inc. 76:206-212.
Weiss et al. (1985), "The Bactericidal/Permeability-Increasing Protein of Neutrophils Retains its Biological Activities After Cleavage by Neutrophil Proteases," Clinical Research 33(2):567(A).
Tobias et al. (1986), "Isolation of a Lipopolysaccharide-Binding Acute Phase Reactant from Rabbit Serum," J. Exp. Med. 164:777-793.
Hovde et al. (1986), "Characterization of a Protein from Normal Human Polymorphonuclear Leukocytes with Bactericidal Activity Against Pseudomonas Aeruginosa," Infection and Immunity 54:142-148.
Weiss et al. (1986), "Environmental Modulation of Lipopolysaccharide Chain Length . . . ," Infection and Immunity 51:594-599.
Ooi et al. (1987), "A 25-KDa NH.sub.2 -Terminal Fragment Carries all the Antibacterial Activities of the Human Neutrophil 60-KDa Bactericidal/Permeability-Increasing Protein," J. Biol. Chem. 262(31):14891-94.
Bone et al. (1987), "A Controlled Clinical Trial of High-Dose Methylprednisolone in the Treatment of Severe Sepsis and Septic Shock," N. Engl. J. of Med. 317(11):653-658.
Weiss et al. (1987), "Cellular and Subcellular Localization of the Bactericidal/Permeability-Increasing Protein of Neutrophils," BA 83(9):86173.
Spitznagel et al. (1987), "A Monoclonal Antibody that Inhibits the Antimicrobial Action of a 57 KD Cationic Protein of Human Polymorphonuclear Leukocytes," J. Immunol. 139:1291-1296.
Farley et al. (1987), "Antimicrobial Binding of a Radiolabeled Cationic Neutrophil Granule Protein," Infection and Immunity 55:1536-1539.
Weiss et al. (1987), "Cellular and Subcellular Localization of the Bactericidal/Permeability-Increasing Protein of Neutrophils," Blood 69(2):652-659.
Harkonen et al. (1988), "Phase I Study of a Murine Monoclonal Anti-Lipid A Antibody in Bacteremic and Nonbacteremic Patients," Antimicrobial Agents and Chemotherapy 32:710-716.
Harkonen et al. (1988), "Clinical Studies of Monoclonal Anti-Lipid A Antibody XMMEN-OE5," Bacterial Endotoxins: Pathophysiological Effects, Clinical Significance, and Pharmacological Control, Alan R. Liss, Inc., pp. 395-406.
Appelmelk et al. (1988), "Production, Characterization and Biological Effects of Monoclonal Antibodies to Different Parts of the Gram-Negative Lipopolysaccharide Core Region," Bacterial Endotoxins: Pathophysiological Effects, Clinical Significance, and Pharmacological Control, Alan R. Liss, Inc., pp. 373-382.
Larrick et al. (1988), "Generation of a Protective Human Monoclonal for the Treatment of Gram-Negative Sepsis," Bacterial Endotoxins: Pathophysiological Effects, Clinical Significance, and Pharmacological Control, Alan R. Liss, Inc., pp. 383-393.
Tobias et al. (1988), "A Family of Lipopolysaccharide Binding Proteins Involved in Responses to Gram-Negative Sepsis," J. Biol. Chem. 263(27):13479-13481.
Gray et al., (1988), "Cloning of the Gene of the Human BPI Protein," Clinical Research 36(3):620A.
Veld et al. (1988), "Effects of the Bactericidal/Permeability-Increasing Protein of Polymorphonuclear Leukocytes on Isolated Bacterial Cytoplasmic Membrane Vesicles," Infection and Immunity 56:1203-1208.
Farley et al. (1988), "Lipopolysaccharide Structure Determines Ionic and Hydrophobic Binding of a Cationic Antimicrobial Neutrophil Granule Protein," Infection and Immunity 56:1589-1592.
Elsbach et al. (1988), "Bactericidal/Permeability Increasing Protein (BPI) of Granulocytes: Structure and Function," Bacteria-Host Cell Interaction, pp. 47-60.
Luckow et al. (1988), "Trends in the Development of Baculovirus Expression Vectors," Bio/Technolog

Affiliated with

Also associated with

Rating

Genetically engineered BPI variant proteins does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Genetically engineered BPI variant proteins, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Genetically engineered BPI variant proteins will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1395452